-
Using Xinzerun to support the new generation｜CSCO/CRPC-Fosun Cancer Supportive Treatment Summit Forum and Aokangze® Listing Meeting was successfully held
Time of Update: 2022-08-12
As we all know, China has fully entered an aging society. At the same time, due to the combined influence of modern life>. In October 2016, the Central Committee of the Communist Party of China and t
-
"Magic medicine" becomes an ideal partner for cancer immunotherapy?
Time of Update: 2022-08-12
Therefore, the results of this study suggest that the use of statins may contribute to the favorable prognosis of NSCLC patients receiving anti- PD-1 monotherapy , and statin therapy may be a combined tool for cancer immunotherapy in NSCLC patients .
-
Lung Cancer: Efficacy and safety of alternating osimertinib and afatinib in treatment-naïve EGFR-mutant advanced non-small cell lung cancer (NSCLC): WJOG10818L
Time of Update: 2022-08-12
Alternating osimertinib and afatinib in patients with epidermal growth factor receptor gene (EGFR)-mutated non-small cell lung cancer (NSCLC) is a promising strategy to overcome osimertinib resistance without compromising safety potential approaches to achieve therapeutic complementarity in the context of Recently, Lung Cancer published the results of a phase II clinical study (WJOG10818L), which mainly evaluated the efficacy and safety of osimertinib and afatinib in the treatment of naïve EGFR-mutated advanced non-small cell lung cancer (NSCLC) .
-
European Radiology: Application of deep learning in predicting the prognosis of radiotherapy-related treatment of laryngeal and hypopharyngeal cancers
Time of Update: 2022-08-12
. The results of the present study demonstrate that a DL model trained using DWI during treatment is a potential imaging marker for predicting treatment response and prognosis in patients with hypopharyngeal and laryngeal cancer undergoing radiotherapy, chemotherapy, or induction (chemo)radiation .
-
European Radiology: Application of microwave ablation and radiofrequency ablation in subcapsular HCC
Time of Update: 2022-08-12
Recently, a study published in European Radiology conducted a retrospective analysis of patients with subcapsular HCC within the Milan criteria and used propensity score matching (PSM) to minimize potential selection and confounding bias for this category.
-
JAMA Oncol: Vistusertib in combination with anastrozole for hormone receptor-positive endometrial cancer
Time of Update: 2022-08-12
. In conclusion, the results of this study show that the addition of anastrozole to the mTOR inhibitor Vistusertib can improve the progression-free rate, remission rate, prolong progression-free survival , and reduce adverse reactions in patients with hormone receptor-positive recurrent/metastatic endometrial cancer.
-
Cancer Discov: Blocking TIGIT is expected to improve the efficacy of CD19-targeting CAR-T cell therapy in non-Hodgkin lymphoma
Time of Update: 2022-08-12
""CAR-T cell therapy is a promising treatment for non-Hodgkin's lymphoma, especially for patients who have relapsed or who have not responded to prior therapy," said co-author Tae Hyun Hwang, MD, an investigator at the Mayo Clinic Cancer Center.
-
Thorac Cancer: The efficacy of pembrolizumab (pembrolizumab) as a single agent in the first-line treatment of elderly NSCLC with high PD-L1 expression
Time of Update: 2022-08-12
. Recently, the journal Thoracic Cancer published the results of a phase II clinical study from Japan, mainly to evaluate the efficacy of Pembrolizumab (pembrolizumab) as a single agent in the first-line treatment of elderly NSCLC with high PD-L1 expression .
-
Selection of Antiemetic Drugs for Explosive Nausea and Vomiting Caused by Chemotherapy
Time of Update: 2022-08-12
Medications for explosive nausea and vomitingIf fulminant vomiting occurs, consider strengthening antiemetic therapy, such as adding NK-1 receptor antagonists or olanzapine, adjusting the dose (intensity or frequency) of 5-HT3 receptor antagonists, combining other antiemetic drugs, adding Use an anti-anxiety medication, consider acid-suppressing therapy (H2 receptor antagonist or proton pump inhibitor PPI), etc.
-
Large-scale case-control study over 12 years: male infertility can double breast cancer risk!
Time of Update: 2022-08-12
. In conclusion, this large case-control study provides strong evidence that male infertility is associated with an increased risk of breast cancer in men .
. In conclusion, this large case-control study provides strong evidence that male infertility is associated with an increased risk of breast cancer in men .
-
Eur Radiol: DSC-PWI enables non-invasive preoperative identification of glioblastoma and metastases!
Time of Update: 2022-08-12
00015)Plot AUC-ROC curves for training (left) and test (right) groups, enhanced tumor (line), peritumoral area (dotted line), and matched combination (bottom) .
00015)Plot AUC-ROC curves for training (left) and test (right) groups, enhanced tumor (line), peritumoral area (dotted line), and matched combination (bottom) .
-
The first domestic case!
Time of Update: 2022-08-12
At 8:47 on May 5, Professor Teng Gaojun , academician of the Chinese Academy of Sciences, president of Zhongda Hospital Affiliated to Southeast University, and director of the interventional diagnosis
-
European Radiology: Application of multiparametric bone MRI in the selection of biopsy targets for bone metastases
Time of Update: 2022-08-12
. This study demonstrates that mpBMRI using a combination of DWI signal, ADC, and rFF can identify active bone metastases suitable for biopsy, while providing high diagnostic yield and NGS feasibility for use as part of interventional imaging efforts in patients with bone metastases Biopsy lesion selection in cancer patients .
-
eLife: NTU Dong Lei's team and others reveal a new mechanism by which haze and cigarette particles aggravate lung cancer
Time of Update: 2022-08-12
Haze and cigarette particles hijack key enzyme molecules, compress extracellular matrix and disrupt tumor immune surveillanceFirst, the authors analyzed the correlation between lung cancer development and early immune defense in the lungs after exposure to fine particulate matter (FPM) .
-
Nature Cancer: Why do some people recover from deadly brain tumors without treatment?
Time of Update: 2022-08-12
. This study demonstrates that triggering ferroptosis significantly inhibits lethal neuroblastoma, suggesting that MYCN-driven tumor cells' high dependence on cysteine is a novel therapeutic avenue that could be exploited to induce cancer cell death.
-
BI-RADS grading standard for breast nodules, this is enough!
Time of Update: 2022-08-12
Grade 3: Benign likely to be high Including a solid mass with smoothed edges, round or oval shape, and a larger transverse diameter than its height, which is likely to be a fibroadenoma; Complex cysts and clustered microcysts were negative on palpation .
-
Eur Radiol: A powerful combination of deep learning and CESM for non-invasive histological analysis of breast cancer!
Time of Update: 2022-08-12
Contrast-enhanced spectral breast imaging (CESM), also known as contrast-enhanced dual-energy breast imaging (CEDM), is an emerging imaging technique that uses intravenous iodinated contrast to assess neovascularization in breast lesions for further evaluation benign and malignant lesions .
-
Cancer Discov: Wu Yilong's team used tumor molecular residual disease (MRD) to accurately predict the recurrence of lung cancer
Time of Update: 2022-08-12
8% The team with Dr. Zhang Jiatao and Director Yang Xuening as the principal investigators used special methods to find out whether there is tumor molecular residual disease (MRD) in the blood through blood tests of patients with early and mid-stage non-small cell lung cancer who have received radical treatment, which can extremely It has a high probability to accurately predict the patient's condition trend, with an accuracy rate of 96.
-
Nature: The Second Hospital of Zhejiang University discovered the secret of the relationship between the olfactory neural circuit and glioma
Time of Update: 2022-08-12
Does the neuronal activity of the olfactory circuit affect the occurrence of gliomas?The Neurosurgery Department of the Second Hospital of Zhejiang University and the team of Professor Liu Chong from the School of Brain Science and Brain Medicine of Zhejiang University have cooperated for a long time to provide the answer to this question .
-
Research new discoveries!
Time of Update: 2022-08-12
Recently, the team of Professor Xia Zanxian from the School of Life Sciences of Central South University published a research paper entitled "M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma" in the international academic journal Molecular Cancer, finding for the first time that circMDK promotes hepatocellular carcinoma Cancer (HCC) progression and new understanding of the pathogenesis of HCC .
